Fig. 2.
Fig. 2. Percentages of donor-derived cells in MRL/lpr mice treated with (5.5 Gy × 2 + PV) or (5.5 Gy × 2 + IV). / HMNCs (closed square), spleen cells (closed circle), and BMCs (closed triangle) in the recipient mice were collected and stained with FITC anti-H-2b mAb to detect donor-derived cells at the days indicated on the X-axis. (A) MRL/lpr mice treated with (5.5 Gy × 2 + PV), (B) MRL/lpr mice treated with (5.5 Gy × 2 + IV). The results are expressed as the mean ± SD of 6 mice.

Percentages of donor-derived cells in MRL/lpr mice treated with (5.5 Gy × 2 + PV) or (5.5 Gy × 2 + IV).

HMNCs (closed square), spleen cells (closed circle), and BMCs (closed triangle) in the recipient mice were collected and stained with FITC anti-H-2b mAb to detect donor-derived cells at the days indicated on the X-axis. (A) MRL/lpr mice treated with (5.5 Gy × 2 + PV), (B) MRL/lpr mice treated with (5.5 Gy × 2 + IV). The results are expressed as the mean ± SD of 6 mice.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal